GLIMEPIRIDE 2mg. IP + METFORMIN 850mg. IP

An oral antidiabetic medication used primarily for the management of type 2 diabetes mellitus, especially in patients inadequately controlled on monotherapy. Improves insulin sensitivity and reduces hepatic glucose production A preferred therapy for managing various diabetes-related complications, such as neuropathy, retinopathy, nephropathy, peripheral vascular disease, diabetic foot, and cardiovascular disorders. (Unnikrishnan Ag, 2020) Helps control blood sugar levels effectively in individuals with diabetes-related complications. (Unnikrishnan Ag, 2020) Helps the pancreas release more insulin, thereby lowering blood sugar levels. A highly effective agent in controlling blood glucose and improving glycated hemoglobin (HbA1c) levels. (KM Prasanna Kumar, 2021) Provides superior glycaemic control compared with glimepiride or metformin monotherapy. (G Charpentier, 2001) Reduces insulin resistance and enhances beta-cell function in the management of type 2 diabetes. A suitable therapeutic approach for both newly diagnosed and long-standing type 2 diabetes patients. (Rakesh Kumar Sahay, 2020)